Dalis S. Sosa-Gutierrez,Jorge F. Toro‐Vázquez,Cynthia Cano-Sarmiento,Peter Grube-Pagola,Alejandro Aparicio‐Saguilán,Cristóbal Torres-Palacios,Andrés Antonio Acosta-Osorio,Hugo S. Garcı́a
出处
期刊:Current Drug Delivery [Bentham Science] 日期:2020-08-19卷期号:18 (2): 212-223被引量:4
Betulinic Acid (BA) is a lipophilic compound with proven beneficial results in topical inflammation. Nanogels (NG) are carriers of bioactive compounds with properties that make them good candidates to treat skin diseases.The objective of this study was to evaluate the anti-inflammatory activity of BA carried in NG.NG were composed of a nanoemulsion and a crosslinking agent (Carbopol 940®) applied at three concentrations (0.5, 1, and 1.5 %) and three activation times (6, 12 and 24 h). In order to select the optimal formulation, the NG were characterized mechanically and micro-structurally followed by evaluation of the BA anti-inflammatory activity in an in vivo model of auricular edema. We determined the edema inhibition activity as percent weight. Additionally, the anti-inflammatory activity of NG was validated through histological analysis.The formulation with the best viscoelastic properties was the one prepared with 0.5% carbopol and 6 h of activation. Microstructural examination of this formulation showed mostly spherical structures with a mean diameter of 65 nm. From the evaluation of edema and the histological analyses, we established that the NG of BA produced 52% inhibition. In contrast, a conventional gel and free BA produced 28% and 19% inhibition, respectively.The NG of BA were found to be good vehicles to treat skin inflammation.